GO:0002232 leukocyte chemotaxis involved in inflammatory response: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002232 describes the directed movement of immune cells in response to an external stimulus that contributes to an inflammatory response.
• The process is driven by chemokine gradients and adhesion molecule interactions between leukocytes and endothelial cells.
• Key genes include chemokine receptors (e.g., CCR2, CXCR4, GPR15), integrins (ITGB2, ITGAL), and adhesion molecules (SELL, ICAM1, VCAM1).
• Dysregulated leukocyte chemotaxis contributes to chronic inflammatory diseases, autoimmune disorders, and cancer progression.
• Experimental models include knockout mice, point-mutation knock-in cells, and overexpression systems to dissect gene function.
• CRISPR-based screening and bioinformatics can identify novel regulators of leukocyte chemotaxis in inflammatory contexts.
Description
Leukocyte chemotaxis involved in inflammatory response (GO:0002232) is a biological process defined as the movement of an immune cell in response to an external stimulus contributing to an inflammatory response. This process is fundamental to host defense, enabling neutrophils, monocytes, eosinophils, and lymphocytes to migrate from the bloodstream to sites of infection or tissue damage. The directed migration requires a coordinated interplay between chemokine receptors, adhesion molecules, and cytoskeletal rearrangements. Researchers study this term to understand how immune cells are recruited during inflammation and how defects in this process lead to diseases such as rheumatoid arthritis, inflammatory bowel disease, and cancer. The QuickGO definition emphasizes that the movement is not random but is triggered by external stimuli and is part of a broader inflammatory response. This article synthesizes current knowledge on the molecular players, regulatory mechanisms, and experimental approaches for investigating GO:0002232, with a focus on CRISPR-based models and high-throughput methods.
leukocyte chemotaxis involved in inflammatory response At A Glance
| GO ID | GO:0002232 |
|---|---|
| GO term | leukocyte chemotaxis involved in inflammatory response |
| Ontology | biological_process |
| Synonym | immune cell chemotaxis during inflammatory response; leucocyte chemotaxis during inflammatory response; leukocyte chemotaxis during inflammatory response |
| Major function | Directed movement of immune cells in response to external stimuli during inflammation |
| Related processes | Leukocyte migration, chemotaxis, inflammatory response, cell adhesion |
| Key molecules | Chemokines, chemokine receptors, integrins, selectins, adhesion molecules |
| Disease relevance | Chronic inflammation, autoimmune diseases, cancer metastasis |
What Is GO:0002232?
In our own words, GO:0002232 refers to the directed migration of leukocytes (white blood cells) toward chemical signals that are generated during an inflammatory response. This process is distinct from general leukocyte chemotaxis because it specifically occurs in the context of inflammation and contributes to the inflammatory response. It involves sensing chemoattractants, adhering to and crossing the endothelium, and moving through tissues along a chemical gradient.
Why Is leukocyte chemotaxis involved in inflammatory response Important in Cell Biology?
Understanding GO:0002232 is critical because leukocyte chemotaxis is a central mechanism in both protective immunity and pathological inflammation. Dysregulated chemotaxis can lead to excessive tissue damage in autoimmune diseases or impaired pathogen clearance in immunodeficiencies. Moreover, leukocyte infiltration into tumors is a hallmark of cancer-related inflammation and can influence tumor progression and response to immunotherapy. Therefore, dissecting the molecular regulators of this process is essential for developing targeted anti-inflammatory therapies and for understanding how immune cells are recruited in various disease contexts.
• Essential for host defense against pathogens by recruiting leukocytes to infection sites.
• Drives tissue damage in chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.
• Plays a role in cancer progression by facilitating tumor-associated macrophage and lymphocyte infiltration.
• Involved in allergic inflammation, including eosinophil recruitment in asthma and gastrointestinal disorders.
• Regulated by chemokine gradients and adhesion molecules, making it a target for anti-inflammatory drugs.
• Dysregulation can lead to immunodeficiency or autoimmunity.
• Provides a model system to study cell migration, signal transduction, and cytoskeletal dynamics.
• Key for understanding how exercise and other physiological states modulate immune cell function.
• Relevant to neuroinflammation and neurodegenerative diseases where immune cell infiltration occurs.
• Can be studied using CRISPR screens to identify novel regulators.
What Happens During leukocyte chemotaxis involved in inflammatory response?
Chemokine Sensing and Receptor Activation
In simple terms: Immune cells detect chemical signals released at the site of inflammation.
Leukocytes express G-protein-coupled chemokine receptors that bind to chemokines produced by inflamed tissues. This binding triggers intracellular signaling cascades, including activation of PI3K and small GTPases, leading to polarized cell morphology and directed migration. For example, GPR15 expressed on T lymphocytes from rheumatoid arthritis patients is involved in chemotaxis to the synovium.
Adhesion to Endothelium
In simple terms: Immune cells stick to blood vessel walls before entering tissues.
Chemokine signaling activates integrins on leukocytes, increasing their affinity for adhesion molecules such as ICAM-1 and VCAM-1 on endothelial cells. This interaction mediates firm adhesion and is a prerequisite for transmigration. Selectins (e.g., L-selectin) mediate initial rolling interactions.
Transmigration Across Endothelium
In simple terms: Immune cells squeeze through the blood vessel wall into the tissue.
After firm adhesion, leukocytes undergo transendothelial migration, a process involving integrins, junctional adhesion molecules, and cytoskeletal rearrangements. This step is tightly regulated and requires the coordination of multiple adhesion and signaling molecules.
Directed Migration in Tissue
In simple terms: Immune cells move toward the source of the chemical signal within the tissue.
Once in the tissue, leukocytes follow chemokine gradients to reach the inflammatory focus. This movement relies on actin polymerization and myosin contraction, and is guided by additional chemoattractants such as complement components and lipid mediators. The acute inflammatory reaction involves sequential recruitment of neutrophils followed by monocytes.
Key Genes Involved in GO:0002232 leukocyte chemotaxis involved in inflammatory response
The following genes and proteins are key players in leukocyte chemotaxis involved in inflammatory response, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCR2 | Chemokine receptor for CCL2, mediates monocyte chemotaxis | Target for anti-inflammatory drugs; KO mice show reduced monocyte recruitment |
| CXCR4 | Chemokine receptor for CXCL12, involved in leukocyte trafficking | Studied in cancer metastasis and inflammation |
| GPR15 | Orphan chemokine receptor, mediates T cell chemotaxis to synovium | Implicated in rheumatoid arthritis |
| ITGB2 | Integrin beta-2 subunit, mediates firm adhesion | Defects cause leukocyte adhesion deficiency |
| ITGAL | Integrin alpha-L subunit, forms LFA-1 with ITGB2 | Essential for leukocyte adhesion and migration |
| SELL | L-selectin, mediates rolling on endothelium | Knockout mice show impaired neutrophil recruitment |
| ICAM1 | Endothelial adhesion molecule for integrins | Upregulated in inflammation; target for blocking antibodies |
| VCAM1 | Endothelial adhesion molecule for VLA-4 | Mediates monocyte and lymphocyte adhesion |
| CCL2 | Chemokine ligand for CCR2 | Major monocyte chemoattractant in inflammation |
| CXCL8 | Chemokine ligand for CXCR1/2, recruits neutrophils | Key mediator of acute inflammation |
| PIK3CD | Phosphoinositide 3-kinase catalytic subunit delta | Regulates chemokine signaling and migration |
| RAC1 | Rho GTPase, regulates actin cytoskeleton | Required for leukocyte polarization and migration |
| CDC42 | Rho GTPase, regulates cell polarity | Involved in directed migration |
| PTK2 | Focal adhesion kinase, mediates integrin signaling | Regulates adhesion turnover during migration |
| MMP9 | Matrix metalloproteinase-9, facilitates tissue invasion | Secreted by neutrophils to degrade extracellular matrix |
| SELPLG | P-selectin glycoprotein ligand-1, mediates rolling | Expressed on leukocytes; interacts with selectins |
| ITGA4 | Integrin alpha-4, forms VLA-4 with ITGB1 | Mediates lymphocyte adhesion to VCAM1 |
How Is leukocyte chemotaxis involved in inflammatory response Regulated?
Leukocyte chemotaxis involved in inflammatory response is regulated at multiple levels. Chemokine receptor expression is modulated by cytokines and transcription factors such as NF-kB. Intracellular signaling pathways, including PI3K/Akt and MAPK, control the strength and directionality of migration. Serotonin has been shown to modulate immune cell functions, including chemotaxis, through specific receptors. Additionally, exercise can affect neutrophil functions, suggesting physiological regulation. The acute inflammatory reaction is self-limited by endogenous anti-inflammatory mediators.
leukocyte chemotaxis involved in inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR15 | Rheumatoid arthritis | Knockout T cells or knock-in reporter for chemotaxis assays |
| CCR2 | Atherosclerosis and multiple sclerosis | CCR2 knockout mice for monocyte recruitment studies |
| ITGB2 | Leukocyte adhesion deficiency | Point mutations in ITGB2 to model LAD |
| CXCR4 | Cancer metastasis | Overexpression in cancer cell lines for migration assays |
| SELL | Inflammatory bowel disease | Knockout mice for neutrophil rolling assays |
Rheumatoid Arthritis
In rheumatoid arthritis, leukocyte chemotaxis contributes to the recruitment of T cells and monocytes into the synovium, leading to chronic inflammation and joint destruction. GPR15 expressed on T lymphocytes from RA patients is involved in chemotaxis to the synovium. Targeting chemokine receptors or adhesion molecules is a therapeutic strategy.
Inflammatory Bowel Disease
In IBD, dysregulated leukocyte chemotaxis leads to excessive infiltration of immune cells into the intestinal mucosa, causing tissue damage. Eosinophils are prominent in gastrointestinal inflammation, and their recruitment is mediated by chemokines. Understanding these pathways can inform new treatments.
Cancer
Leukocyte chemotaxis in the tumor microenvironment can promote tumor progression by recruiting immunosuppressive cells such as regulatory T cells and tumor-associated macrophages. Chemokine receptors like CXCR4 are implicated in metastasis. Targeting chemotaxis pathways is being explored for cancer immunotherapy.
Acute Inflammation and Sepsis
During acute inflammation, excessive neutrophil chemotaxis can lead to tissue damage and organ failure in sepsis. The acute inflammatory reaction involves coordinated recruitment of leukocytes, and its dysregulation contributes to pathology. Modulating chemotaxis may be beneficial in severe inflammation.
From leukocyte chemotaxis involved in inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate leukocyte chemotaxis? | CRISPR knockout in primary leukocytes or cell lines (e.g., HL-60, Jurkat) |
| What is the effect of a specific point mutation in a chemokine receptor? | CRISPR point mutation knock-in in cell lines |
| How does overexpression of a chemokine affect migration? | CRISPR knock-in of a constitutive promoter or lentiviral overexpression |
| Can we visualize chemotaxis in real time? | Tagged knock-in of fluorescent proteins (e.g., GFP) in leukocytes |
| What are the global regulators of chemotaxis? | CRISPR library screening with chemotaxis readout |
| How does a disease-associated SNP affect chemotaxis? | CRISPR knock-in of the SNP in a relevant cell model |
How to Study the leukocyte chemotaxis involved in inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell migration assay | Number of cells migrating through a membrane | Screening chemokine receptors |
| Microfluidic chemotaxis | Directionality and speed of migration | Studying gradient sensing |
| Flow adhesion assay | Firm adhesion under shear flow | Evaluating integrin function |
| Live-cell imaging | Dynamic cell movement and morphology | Visualizing transmigration |
| RNA-seq | Transcriptional changes during chemotaxis | Identifying novel regulators |
| Proteomics | Protein expression and modifications | Mapping signaling pathways |
| CRISPR screen | Genes required for chemotaxis | Unbiased discovery of regulators |
| Intravital microscopy | Leukocyte behavior in live animals | Studying inflammation in vivo |
In Vitro Chemotaxis Assays
Transwell and microfluidic chemotaxis assays are standard methods to measure leukocyte migration toward chemoattractants. These assays can be combined with CRISPR knockout to assess gene function.
Live-Cell Imaging
Time-lapse microscopy of fluorescently tagged leukocytes allows visualization of migration dynamics and interactions with endothelial cells. This method is useful for studying the steps of transmigration.
Flow Cytometry and Adhesion Assays
Flow cytometry can quantify integrin activation and adhesion molecule expression. Static adhesion assays under flow conditions mimic physiological shear stress.
Transcriptomics and Proteomics
RNA-seq and proteomics can identify genes and proteins differentially expressed during chemotaxis. These approaches are often used in combination with CRISPR screens to validate hits.
How CRISPR Can Be Used to Study GO:0002232 leukocyte chemotaxis involved in inflammatory response
Knockout
CRISPR knockout of candidate genes in leukocyte cell lines or primary cells can determine whether a gene is required for chemotaxis. For example, knocking out CCR2 in monocytes abolishes CCL2-induced migration.
Point Mutation
Point mutations can be introduced to model disease-associated variants or to dissect specific residues in chemokine receptors or integrins. This is useful for understanding how single amino acid changes affect ligand binding or signaling.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or reporter genes allows real-time tracking of leukocyte migration. Knock-in of human disease alleles into mouse models can recapitulate human phenotypes.
Overexpression
Overexpression of chemokines or chemokine receptors can enhance or alter chemotaxis. This approach is used to study gain-of-function effects in inflammatory diseases and cancer.
How EDITGENE Supports leukocyte chemotaxis involved in inflammatory response Research
Researchers studying leukocyte chemotaxis involved in inflammatory response-related genes often need to determine whether a candidate gene is causally involved in the migration process or merely a bystander. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic manipulation in immune cells and model systems.
Contact EDITGENE today to design your custom CRISPR model for leukocyte chemotaxis involved in inflammatory response research.
Frequently Asked Questions About leukocyte chemotaxis involved in inflammatory response
What is GO:0002232?
GO:0002232 is the Gene Ontology term for leukocyte chemotaxis involved in inflammatory response, defined as the movement of an immune cell in response to an external stimulus contributing to an inflammatory response.
What genes are involved in leukocyte chemotaxis involved in inflammatory response?
Key genes include chemokine receptors (CCR2, CXCR4, GPR15), integrins (ITGB2, ITGAL), selectins (SELL), and adhesion molecules (ICAM1, VCAM1).
How is leukocyte chemotaxis involved in inflammatory response regulated?
It is regulated by chemokine gradients, integrin activation, and intracellular signaling pathways such as PI3K/Akt and MAPK. Serotonin and exercise can also modulate it.
What diseases are associated with leukocyte chemotaxis involved in inflammatory response?
Diseases include rheumatoid arthritis, inflammatory bowel disease, cancer, and sepsis.
What methods are used to study leukocyte chemotaxis involved in inflammatory response?
Common methods include Transwell assays, microfluidic chemotaxis, live-cell imaging, flow cytometry, and CRISPR screens.
Can CRISPR be used to study leukocyte chemotaxis involved in inflammatory response?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect gene function in chemotaxis.
What is the role of GPR15 in leukocyte chemotaxis involved in inflammatory response?
GPR15 expressed on T lymphocytes from rheumatoid arthritis patients is involved in chemotaxis to the synovium.
How does leukocyte chemotaxis contribute to cancer?
Leukocyte chemotaxis can recruit immunosuppressive cells to the tumor microenvironment, promoting tumor progression and metastasis.
What is the difference between leukocyte chemotaxis and general chemotaxis?
Leukocyte chemotaxis involved in inflammatory response specifically occurs in the context of inflammation and contributes to the inflammatory response, whereas general chemotaxis can occur in other contexts.
What are the key steps in leukocyte chemotaxis involved in inflammatory response?
The key steps are chemokine sensing, adhesion to endothelium, transmigration, and directed migration within tissue.
Conclusion
Leukocyte chemotaxis involved in inflammatory response (GO:0002232) is a fundamental biological process that orchestrates immune cell recruitment during inflammation. Its dysregulation underlies numerous diseases, making it a prime target for therapeutic intervention. Advances in CRISPR technology and high-throughput screening are accelerating the discovery of novel regulators and the development of precise models to study this process. EDITGENE offers a comprehensive toolkit to support researchers in dissecting the molecular mechanisms of leukocyte chemotaxis and translating findings into clinical applications.
References
- 1. Rothenberg ME et al.. 2001. Gastrointestinal eosinophils.. Immunol Rev 179:139-55 PMID: 11292017
- 2. Muller WA. 2003. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response.. Trends Immunol 24(6):327-34 PMID: 12810109
- 3. Arreola R et al.. 2015. Immunomodulatory effects mediated by serotonin.. J Immunol Res 2015:354957 PMID: 25961058
- 4. Carlos TM et al.. 1994. Leukocyte-endothelial adhesion molecules.. Blood 84(7):2068-101 PMID: 7522621
- 5. Langer HF et al.. 2009. Leukocyte-endothelial interactions in inflammation.. J Cell Mol Med 13(7):1211-20 PMID: 19538472
- 6. Gavrieli R et al.. 2008. The effect of aerobic exercise on neutrophil functions.. Med Sci Sports Exerc 40(9):1623-8 PMID: 18685529
- 7. Fernández-Ruiz JC et al.. 2022. GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the synovium.. J Leukoc Biol 112(5):1209-1221 PMID: 36164808
- 8. Ward PA et al.. 1989. The acute inflammatory reaction.. Curr Opin Immunol 2(1):5-9 PMID: 2482043
